DeepSeek addition to ClouDr medical AI platform drives share-price surge

ClouDr Group's shares have surged after integrating DeepSeek's AI technology, enhancing its platform's efficiency in healthcare operations. This move has led to a notable increase in the company's stock value, reaching a four-month high. The integration aims to improve data-mining capabilities, specifically for chronic patient management, as stated by ClouDr's CEO Kuang Ming.

DeepSeek has gained traction in China as a prominent tech start-up due to its efficient open-source large language models, which have impressed experts globally. The V3 model, launched recently, was developed at a comparatively low cost and with fewer resources, highlighting its competitive advantage. ClouDr's adoption of this technology allows for upgrades in its medical knowledge systems and clinical decision-support, leveraging a vast database of electronic health records to enhance diagnostic processes. Both companies are situated in Hangzhou, underscoring the region's growing influence in the tech industry.

via SCMP Full Text Feed
 
 
Back to Top